- Ovarian cancer screening in menopausal females with a family history of breast or ovarian cancer
-
Lai T, Kessel B, Ahn HJ, Terada KY
- KMID: 2374243
- J Gynecol Oncol.
- 2016 Jul;27(4):e41.
- doi: 10.3802/jgo.2016.27.e41
OBJECTIVE: To determine whether annual screening reduces ovarian cancer mortality in women with a family history of breast or ovarian cancer. METHODS: Data was obtained from the Prostate, Lung, Colorectal, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Differences in risk for type 1 and type 2 ovarian cancer in a large cancer screening trial
-
Terada KY, Ahn HJ, Kessel B
- KMID: 2363319
- J Gynecol Oncol.
- 2016 May;27(3):e25.
- doi: 10.3802/jgo.2016.27.e25
OBJECTIVE: To investigate the role of previous gynecologic surgery, hormone use, and use of non-steroidal anti-inflammatory drugs on the risk of type 1 and type 2 ovarian cancer. METHODS: We utilized... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of 17β-Estradiol on the Plasminogen Activator System in Vascular Smooth Muscle Cells Treated with Lysophophatidylcholine
-
Yoon BK, Kang YH, Oh WJ, Lee DY, Kim DK, Kessel B, Kang CD
- KMID: 2500637
- J Menopausal Med.
- 2020 Apr;26(1):9-17.
- doi: 10.6118/jmm.19005
Objectives: When administered soon after menopause, hormone therapy can prevent coronary heart diseases in women. To explore the mechanism underlying the cardioprotective actions of estrogen, we investigated the effects of... -
- CITED
-
- Close
- SHARE
-
- Close
